BACKGROUND: The purpose of this study was to evaluate long-term outcomes after induction chemotherapy followed by "risk-based" local therapy for locally-advanced squamous cell carcinoma of the head and neck (SCCHN). METHODS: Forty-seven patients (stage IV; ≥N2b) were enrolled in a phase II trial. Baseline and 24-month functional measures included modified barium swallow (MBS) studies, oropharyngeal swallow efficiency (OPSE), and the MD Anderson Dysphagia Inventory (MDADI). Functional status was assessed at 5 years. RESULTS: Five-year overall survival (OS) was 89% (95% confidence interval [CI], 81% to 99%). A nonsignificant 13% average reduction in swallowing efficiency (OPSE) was observed at 24 months relative to baseline (p = .191). MDADI scores approximated baseline at 24 months. Among 42 long-term survivors (median, 5.9 years), 3 patients (7.1%) had chronic dysphagia. The rate of final gastrostomy dependence was 4.8% (2 of 42). CONCLUSION: Sequential chemoradiotherapy achieved favorable outcomes among patients with locally advanced SCCHN, mainly of oropharyngeal origin. MBS and MDADI scores found modest swallowing deterioration at 2 years, and chronic aspiration was uncommon in long-term survivors.
BACKGROUND: The purpose of this study was to evaluate long-term outcomes after induction chemotherapy followed by "risk-based" local therapy for locally-advanced squamous cell carcinoma of the head and neck (SCCHN). METHODS: Forty-seven patients (stage IV; ≥N2b) were enrolled in a phase II trial. Baseline and 24-month functional measures included modified barium swallow (MBS) studies, oropharyngeal swallow efficiency (OPSE), and the MD Anderson Dysphagia Inventory (MDADI). Functional status was assessed at 5 years. RESULTS: Five-year overall survival (OS) was 89% (95% confidence interval [CI], 81% to 99%). A nonsignificant 13% average reduction in swallowing efficiency (OPSE) was observed at 24 months relative to baseline (p = .191). MDADI scores approximated baseline at 24 months. Among 42 long-term survivors (median, 5.9 years), 3 patients (7.1%) had chronic dysphagia. The rate of final gastrostomy dependence was 4.8% (2 of 42). CONCLUSION: Sequential chemoradiotherapy achieved favorable outcomes among patients with locally advanced SCCHN, mainly of oropharyngeal origin. MBS and MDADI scores found modest swallowing deterioration at 2 years, and chronic aspiration was uncommon in long-term survivors.
Authors: David L Schwartz; Katherine Hutcheson; Denise Barringer; Susan L Tucker; Merrill Kies; F Christopher Holsinger; K Kian Ang; William H Morrison; David I Rosenthal; Adam S Garden; Lei Dong; Jan S Lewin Journal: Int J Radiat Oncol Biol Phys Date: 2010-06-18 Impact factor: 7.038
Authors: Daniel J Givens; Lucy Hynds Karnell; Anjali K Gupta; Gerald H Clamon; Nitin A Pagedar; Kristi E Chang; Douglas J Van Daele; Gerry F Funk Journal: Arch Otolaryngol Head Neck Surg Date: 2009-12
Authors: David O Francis; Ernest A Weymuller; Upendra Parvathaneni; Albert L Merati; Bevan Yueh Journal: Ann Otol Rhinol Laryngol Date: 2010-06 Impact factor: 1.547
Authors: Jay S Cooper; Kim Porter; Katherine Mallin; Henry T Hoffman; Randal S Weber; Kian K Ang; E Greer Gay; Corey J Langer Journal: Head Neck Date: 2009-06 Impact factor: 3.147
Authors: C Arturo Solares; Benjamin Wood; Cristina P Rodriguez; Robert R Lorenz; Joseph Scharpf; Jerrold Saxton; Lisa A Rybicki; Marshall Strome; Ramon Esclamado; Pierre Lavertu; David J Adelstein Journal: Laryngoscope Date: 2009-06 Impact factor: 3.325
Authors: Robert I Haddad; Roy B Tishler; Charles Norris; Laura Goguen; Tracy A Balboni; Rosemary Costello; Lori Wirth; Jochen Lorch; Britta Andreozzi; Donald Annino; Marshall R Posner Journal: J Clin Oncol Date: 2009-08-24 Impact factor: 44.544
Authors: Jimmy J Caudell; Philip E Schaner; Ruby F Meredith; Julie L Locher; Lisle M Nabell; William R Carroll; J Scott Magnuson; Sharon A Spencer; James A Bonner Journal: Int J Radiat Oncol Biol Phys Date: 2008-07-16 Impact factor: 7.038
Authors: Merrill S Kies; Floyd Christopher Holsinger; J Jack Lee; William N William; Bonnie S Glisson; Heather Y Lin; Jan S Lewin; Lawrence E Ginsberg; Katharine A Gillaspy; Erminia Massarelli; Lauren Byers; Scott M Lippman; Waun K Hong; Adel K El-Naggar; Adam S Garden; Vassiliki Papadimitrakopoulou Journal: J Clin Oncol Date: 2009-11-16 Impact factor: 44.544
Authors: Mitchell Machtay; Jennifer Moughan; Andrew Trotti; Adam S Garden; Randal S Weber; Jay S Cooper; Arlene Forastiere; K Kian Ang Journal: J Clin Oncol Date: 2008-06-16 Impact factor: 44.544
Authors: Jeffrey M Vainshtein; Dominic H Moon; Felix Y Feng; Douglas B Chepeha; Avraham Eisbruch; Matthew H Stenmark Journal: Int J Radiat Oncol Biol Phys Date: 2015-04-01 Impact factor: 7.038
Authors: Ryan P Goepfert; Jan S Lewin; Martha P Barrow; Carla L Warneke; Clifton D Fuller; Stephen Y Lai; Randal S Weber; Katherine A Hutcheson Journal: Dysphagia Date: 2017-08-23 Impact factor: 3.438
Authors: Katherine A Hutcheson; Maggie Yuk; Rachel Hubbard; Gary B Gunn; C David Fuller; Stephen Y Lai; Heather Lin; Adam S Garden; David I Rosenthal; Ehab Y Hanna; Merrill S Kies; Jan S Lewin Journal: Head Neck Date: 2017-04-28 Impact factor: 3.147
Authors: Molly K Barnhart; Rachelle A Robinson; Virginia A Simms; Elizabeth C Ward; Bena Cartmill; Sophie J Chandler; Robert I Smee Journal: Support Care Cancer Date: 2018-02-07 Impact factor: 3.603
Authors: Katherine A Hutcheson; Martha P Barrow; Asher Lisec; Denise A Barringer; Kacie Gries; Jan S Lewin Journal: Laryngoscope Date: 2015-11-06 Impact factor: 3.325